Antidepressant use continues to rise yet the jury is still out on the drugs' effectiveness for the most common forms of depression, writes Scientia Professor Philip Mitchell.
Harnessing genetic science to head off major depressive disorder, the world’s leading cause of disability, is fraught with controversy, writes Dr Alex Wilde.
A compound originally designed to treat leukaemia could also be effective in preventing asthma.
UNSW researchers have discovered a strain of norovirus they warn could cause a severe epidemic of acute gastroenteritis in Australia this winter.
A UNSW-affiliated researcher is one of six young people awarded Cancer Institute NSW grants to find new ways to help prevent and treat cancer.
A world-first study is under way looking at the genetic predisposition of some people to become depressed after bereavement.
Groundbreaking work on HIV, cardiovascular disease and improving patient safety are among the major UNSW research programs to be awarded funding by the National Health and Medical Research Council.
Young people with a known genetic risk of bipolar disorder but no clinical signs of the condition show reduced reaction to facial emotions, a new brain imaging study has found.
The burden of major depression and anxiety have each increased by 37 per cent in 20 years, according to the Global Burden of Disease report.
Ketamine may be useful as an antidepressant in urgent situations – where the patient is seriously depressed and acutely suicidal – and where other treatments have failed, writes Colleen Loo.